Detalhe da pesquisa
1.
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Am J Addict
; 32(3): 291-300, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645265
2.
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.
Am J Addict
; 32(6): 584-592, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583120
3.
Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound.
J Ultrasound Med
; 42(10): 2315-2330, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209359
4.
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.
Am J Drug Alcohol Abuse
; 49(5): 618-629, 2023 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791817
5.
Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis.
Genet Med
; 24(1): 15-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906494
6.
Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment.
AIDS Behav
; 26(2): 385-396, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331177
7.
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.
Addict Biol
; 27(2): e13112, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877769
8.
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.
Subst Use Misuse
; 57(11): 1732-1742, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975917
9.
The Impact of Aerobic Training on Cardiovascular Reactivity to and Recovery From Psychological and Orthostatic Challenge.
Psychosom Med
; 83(2): 125-137, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33337592
10.
Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial.
Alcohol Clin Exp Res
; 45(12): 2569-2578, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698397
11.
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder.
Alcohol Clin Exp Res
; 45(8): 1639-1652, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120336
12.
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.
Am J Addict
; 30(5): 433-444, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075644
13.
Open-label pilot study of lisdexamfetamine for cocaine use disorder.
Am J Drug Alcohol Abuse
; 47(3): 402-409, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797985
14.
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder.
Am J Drug Alcohol Abuse
; 47(4): 467-475, 2021 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092158
15.
Psychological Symptoms and Outcomes in Adults Receiving Community-based Treatment for Substance Use Disorders.
Subst Use Misuse
; 56(9): 1258-1265, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882788
16.
Development of a prognostic tool exploring female adolescent risk for HIV prevention and PrEP in rural South Africa, a generalised epidemic setting.
Sex Transm Infect
; 96(1): 47-54, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31326947
17.
DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence.
AIDS Care
; 32(5): 645-650, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682153
18.
A pilot randomized controlled trial of hearing aids to improve mood and cognition in older adults.
Int J Geriatr Psychiatry
; 35(8): 842-850, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32291802
19.
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder.
Am J Addict
; 29(6): 536-542, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438502
20.
Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.
Am J Drug Alcohol Abuse
; 46(1): 44-48, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31339797